Please assess the completion status of the following clinical trial:

Trial Title: Study Using WST11 in Patients With Obstructing Endobronchial Non-Small Cell Lung Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically proven lung cancer~* Inoperable~* Non-Small Cell Cancer~* Partial or total bronchial obstruction responsible for functional signs~* T1 to T4, N0-N3, M0-M1~* Patients with functional signs: hemoptysis, infection, cough and, above all, dyspnea~* Contralateral metastases not representing a contraindication insofar as they do not represent a risk of impairment of respiratory function during treatment~* The Karnofsky index should be greater than or equal to 40~* Patients should agree to and tolerate repeated bronchial endoscopy (a disadvantage of all endoscopic treatments)~* Male or female patients aged over 18 years, female patients should not be pregnant (menopause or contraception)~* Patients should have given their written consent to take part in the study~Exclusion Criteria:~* Tracheal lesions and lesions affecting the carina tracheae~* Patients with painful bone metastases (not an absolute criterion since the extent of dyspnea is the decisive element)~* Patients with brain metastases~* Patients having undergone pneumonectomy~* Patients undergoing chemotherapy or radiotherapy or having undergone chemotherapy less than 4 weeks before the procedure or radiotherapy less than 4 weeks before the procedure~* Patients with risk of large vessel erosion or perforation resulting from lesion topography~* In case of allergy to the photosensitizer~* Leukopenia (WBC\<2000), Thrombocytopenia (\< 100 000), PT \> 1.5 normal, Fibrinogen \< 2g/l, a PTT \> 1.5 ULN (Upper Limit of Normal)~* Renal insufficiency~* Hepatic insufficiency~* Patients having already received 70 Gy on the lesion~* Existing tracheoesophageal or bronchoesophageal fistula~* Emergency treatment of patients with severe acute respiratory distress caused by an obstructing endobronchial lesion

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- WST11 (Type: EXPERIMENTAL): Treatment with WST11-mediated VTP

Based on this trial design, predict the completion outcome and termination type (if applicable).